Abstract

Kinetin has been shown to have anti-aging effects on several different systems including plants and human cells. The aim of this study was to examine the detailed inhibitory mechanisms of kinetin in platelet aggregation. In this study, kinetin concentration-dependently (50-150 μM) inhibited platelet aggregation in human platelets stimulated by agonists. Kinetin (70 and 150 μM) also concentration-dependently inhibited intracellular Ca2+ mobilization and phosphoinositide breakdown in platelets stimulated by collagen (1 μg/ml). Kinetin (70 and 150 μM) significantly inhibited thromboxane A2 formation stimulated by collagen (1 μg/ml) and arachidonic acid (60 μM) in human platelets. In addition, kinetin (70 and 150 μM) significantly increased the formation of cyclic AMP. Intracellular pH values were measured spectrofluorometrically using the fluorescent probe BCECF-AM in platelets. The thrombin-evoked increase in pHi was markedly inhibited in the presence of kinetin (70 and 150 μM). Rapid phosphorylation of a platelet protein of molecular weight (Mr) 47 000 (P47), a marker of protein kinase C activation, was triggered by collagen (1 μg/ml). This phosphorylation was inhibited by kinetin (70 and 150 μM). In conclusion, these results indicate that the anti-platelet activity of kinetin may be involved in the following pathways: kinetin's effects may initially be due to inhibition of the activation of phospholipase C and the Na+/H+ exchanger. This leads to lower intracellular Ca2+ mobilization, followed by inhibition of TxA2 formation and then increased cyclic AMP formation, followed by a further inhibition of the Na+/H+ exchanger, ultimately resulting in markedly decreased intracellular Ca2+ mobilization and phosphorylation of P47. These results suggest that kinetin has an effective anti-platelet effect and that it may be a potential therapeutic agent for arterial thrombosis.

Original languageEnglish
Pages (from-to)189-196
Number of pages8
JournalPlatelets
Volume14
Issue number3
DOIs
Publication statusPublished - May 2003

Fingerprint

Kinetin
Platelet Aggregation
Growth Hormone
Blood Platelets
Sodium-Hydrogen Antiporter
Collagen
Phosphorylation
Cyclic AMP
Thromboxane A2
Plant Cells
Type C Phospholipases
Phosphatidylinositols
Fluorescent Dyes
Arachidonic Acid
Thrombin
Protein Kinase C
Thrombosis
Molecular Weight

ASJC Scopus subject areas

  • Hematology
  • Cell Biology

Cite this

Inhibitory mechanisms of kinetin, a plant growth-promoting hormone, in platelet aggregation. / Sheu, Joen Rong; Hsiao, G.; Shen, M. Y.; Chou, C. Y.; Lin, C. H.; Chen, Tzeng-Fu; Chou, D. S.; Shen, J. R.

In: Platelets, Vol. 14, No. 3, 05.2003, p. 189-196.

Research output: Contribution to journalArticle

Sheu, Joen Rong ; Hsiao, G. ; Shen, M. Y. ; Chou, C. Y. ; Lin, C. H. ; Chen, Tzeng-Fu ; Chou, D. S. ; Shen, J. R. / Inhibitory mechanisms of kinetin, a plant growth-promoting hormone, in platelet aggregation. In: Platelets. 2003 ; Vol. 14, No. 3. pp. 189-196.
@article{a412aaae9f6540b9a0810fb0c0a38d1d,
title = "Inhibitory mechanisms of kinetin, a plant growth-promoting hormone, in platelet aggregation",
abstract = "Kinetin has been shown to have anti-aging effects on several different systems including plants and human cells. The aim of this study was to examine the detailed inhibitory mechanisms of kinetin in platelet aggregation. In this study, kinetin concentration-dependently (50-150 μM) inhibited platelet aggregation in human platelets stimulated by agonists. Kinetin (70 and 150 μM) also concentration-dependently inhibited intracellular Ca2+ mobilization and phosphoinositide breakdown in platelets stimulated by collagen (1 μg/ml). Kinetin (70 and 150 μM) significantly inhibited thromboxane A2 formation stimulated by collagen (1 μg/ml) and arachidonic acid (60 μM) in human platelets. In addition, kinetin (70 and 150 μM) significantly increased the formation of cyclic AMP. Intracellular pH values were measured spectrofluorometrically using the fluorescent probe BCECF-AM in platelets. The thrombin-evoked increase in pHi was markedly inhibited in the presence of kinetin (70 and 150 μM). Rapid phosphorylation of a platelet protein of molecular weight (Mr) 47 000 (P47), a marker of protein kinase C activation, was triggered by collagen (1 μg/ml). This phosphorylation was inhibited by kinetin (70 and 150 μM). In conclusion, these results indicate that the anti-platelet activity of kinetin may be involved in the following pathways: kinetin's effects may initially be due to inhibition of the activation of phospholipase C and the Na+/H+ exchanger. This leads to lower intracellular Ca2+ mobilization, followed by inhibition of TxA2 formation and then increased cyclic AMP formation, followed by a further inhibition of the Na+/H+ exchanger, ultimately resulting in markedly decreased intracellular Ca2+ mobilization and phosphorylation of P47. These results suggest that kinetin has an effective anti-platelet effect and that it may be a potential therapeutic agent for arterial thrombosis.",
author = "Sheu, {Joen Rong} and G. Hsiao and Shen, {M. Y.} and Chou, {C. Y.} and Lin, {C. H.} and Tzeng-Fu Chen and Chou, {D. S.} and Shen, {J. R.}",
year = "2003",
month = "5",
doi = "10.1080/0953710021000060925",
language = "English",
volume = "14",
pages = "189--196",
journal = "Platelets",
issn = "0953-7104",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Inhibitory mechanisms of kinetin, a plant growth-promoting hormone, in platelet aggregation

AU - Sheu, Joen Rong

AU - Hsiao, G.

AU - Shen, M. Y.

AU - Chou, C. Y.

AU - Lin, C. H.

AU - Chen, Tzeng-Fu

AU - Chou, D. S.

AU - Shen, J. R.

PY - 2003/5

Y1 - 2003/5

N2 - Kinetin has been shown to have anti-aging effects on several different systems including plants and human cells. The aim of this study was to examine the detailed inhibitory mechanisms of kinetin in platelet aggregation. In this study, kinetin concentration-dependently (50-150 μM) inhibited platelet aggregation in human platelets stimulated by agonists. Kinetin (70 and 150 μM) also concentration-dependently inhibited intracellular Ca2+ mobilization and phosphoinositide breakdown in platelets stimulated by collagen (1 μg/ml). Kinetin (70 and 150 μM) significantly inhibited thromboxane A2 formation stimulated by collagen (1 μg/ml) and arachidonic acid (60 μM) in human platelets. In addition, kinetin (70 and 150 μM) significantly increased the formation of cyclic AMP. Intracellular pH values were measured spectrofluorometrically using the fluorescent probe BCECF-AM in platelets. The thrombin-evoked increase in pHi was markedly inhibited in the presence of kinetin (70 and 150 μM). Rapid phosphorylation of a platelet protein of molecular weight (Mr) 47 000 (P47), a marker of protein kinase C activation, was triggered by collagen (1 μg/ml). This phosphorylation was inhibited by kinetin (70 and 150 μM). In conclusion, these results indicate that the anti-platelet activity of kinetin may be involved in the following pathways: kinetin's effects may initially be due to inhibition of the activation of phospholipase C and the Na+/H+ exchanger. This leads to lower intracellular Ca2+ mobilization, followed by inhibition of TxA2 formation and then increased cyclic AMP formation, followed by a further inhibition of the Na+/H+ exchanger, ultimately resulting in markedly decreased intracellular Ca2+ mobilization and phosphorylation of P47. These results suggest that kinetin has an effective anti-platelet effect and that it may be a potential therapeutic agent for arterial thrombosis.

AB - Kinetin has been shown to have anti-aging effects on several different systems including plants and human cells. The aim of this study was to examine the detailed inhibitory mechanisms of kinetin in platelet aggregation. In this study, kinetin concentration-dependently (50-150 μM) inhibited platelet aggregation in human platelets stimulated by agonists. Kinetin (70 and 150 μM) also concentration-dependently inhibited intracellular Ca2+ mobilization and phosphoinositide breakdown in platelets stimulated by collagen (1 μg/ml). Kinetin (70 and 150 μM) significantly inhibited thromboxane A2 formation stimulated by collagen (1 μg/ml) and arachidonic acid (60 μM) in human platelets. In addition, kinetin (70 and 150 μM) significantly increased the formation of cyclic AMP. Intracellular pH values were measured spectrofluorometrically using the fluorescent probe BCECF-AM in platelets. The thrombin-evoked increase in pHi was markedly inhibited in the presence of kinetin (70 and 150 μM). Rapid phosphorylation of a platelet protein of molecular weight (Mr) 47 000 (P47), a marker of protein kinase C activation, was triggered by collagen (1 μg/ml). This phosphorylation was inhibited by kinetin (70 and 150 μM). In conclusion, these results indicate that the anti-platelet activity of kinetin may be involved in the following pathways: kinetin's effects may initially be due to inhibition of the activation of phospholipase C and the Na+/H+ exchanger. This leads to lower intracellular Ca2+ mobilization, followed by inhibition of TxA2 formation and then increased cyclic AMP formation, followed by a further inhibition of the Na+/H+ exchanger, ultimately resulting in markedly decreased intracellular Ca2+ mobilization and phosphorylation of P47. These results suggest that kinetin has an effective anti-platelet effect and that it may be a potential therapeutic agent for arterial thrombosis.

UR - http://www.scopus.com/inward/record.url?scp=0012765444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0012765444&partnerID=8YFLogxK

U2 - 10.1080/0953710021000060925

DO - 10.1080/0953710021000060925

M3 - Article

C2 - 12850843

AN - SCOPUS:0012765444

VL - 14

SP - 189

EP - 196

JO - Platelets

JF - Platelets

SN - 0953-7104

IS - 3

ER -